Detalhe da pesquisa
1.
Virological characterization of treatment failures and retreatment outcomes in patients infected with "unusual" HCV genotype 1 subtypes.
Hepatology
; 78(2): 607-620, 2023 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36999537
2.
Unknown Circovirus in Immunosuppressed Patient with Hepatitis, France, 2022.
Emerg Infect Dis
; 29(5): 1051-1054, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37081594
3.
Diagnostic Accuracy of Assays Using Point-of-Care Testing or Dried Blood Spot Samples for the Determination of Hepatitis C Virus RNA: A Systematic Review.
J Infect Dis
; 226(6): 1005-1021, 2022 09 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-35150578
4.
Hepatitis B, C, and delta in the general population in Mayotte: hepatitis B as a major public health concern.
BMC Infect Dis
; 22(1): 716, 2022 Aug 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-36038821
5.
A Highly Prevalent Polymorphism in the Core Region Impairs Quantification of Hepatitis B Virus (HBV) by the cobas TaqMan HBV Assay.
J Clin Microbiol
; 58(9)2020 08 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-32669381
6.
Grazoprevir/elbasvir for the immediate treatment of recently acquired HCV genotype 1 or 4 infection in MSM.
J Antimicrob Chemother
; 75(7): 1961-1968, 2020 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32306039
7.
Sofosbuvir-Daclatasvir is suboptimal in patients with genotype 2 chronic hepatitis C infection: real-life experience from the HEPATHER ANRS CO22 cohort.
J Viral Hepat
; 27(10): 964-973, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32436335
8.
Frequent Antiviral Treatment Failures in Patients Infected With Hepatitis C Virus Genotype 4, Subtype 4r.
Hepatology
; 69(2): 513-523, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30125371
9.
In-field evaluation of Xpert® HCV viral load Fingerstick assay in people who inject drugs in Tanzania.
Liver Int
; 40(3): 514-521, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31778282
10.
French hepatitis C care cascade: substantial impact of direct-acting antivirals, but the road to elimination is still long.
BMC Infect Dis
; 20(1): 759, 2020 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33059617
11.
High prevalence and poor linkage to care of transfusion-transmitted infections among blood donors in Dar-es-Salaam, Tanzania.
J Viral Hepat
; 26(6): 750-756, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30712273
12.
Primary resistance of hepatitis B virus to nucleoside and nucleotide analogues.
J Viral Hepat
; 26(2): 278-286, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30339311
13.
12 Weeks of a Ribavirin-Free Sofosbuvir and Nonstructural Protein 5A Inhibitor Regimen Is Enough to Treat Recurrence of Hepatitis C After Liver Transplantation.
Hepatology
; 68(4): 1277-1287, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29633389
14.
Prevalence of hepatitis C infection, screening and associated factors among men who have sex with men attending gay venues: a cross-sectional survey (PREVAGAY), France, 2015.
BMC Infect Dis
; 19(1): 315, 2019 Apr 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30971207
15.
HCV and HBV prevalence based on home blood self-sampling and screening history in the general population in 2016: contribution to the new French screening strategy.
BMC Infect Dis
; 19(1): 896, 2019 Oct 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-31660879
16.
New virological tools for screening, diagnosis and monitoring of hepatitis B and C in resource-limited settings.
J Hepatol
; 69(4): 916-926, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29800630
17.
The hepatitis C cascade of care in people who inject drugs in Dar es Salaam, Tanzania.
J Viral Hepat
; 25(12): 1438-1445, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29974582
18.
Sofosbuvir-Daclatasvir-Simeprevir Plus Ribavirin in Direct-Acting Antiviral-Experienced Patients With Hepatitis C.
Clin Infect Dis
; 64(11): 1615-1618, 2017 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28369411
19.
The New Aptima HBV Quant Real-Time TMA Assay Accurately Quantifies Hepatitis B Virus DNA from Genotypes A to F.
J Clin Microbiol
; 55(4): 1211-1219, 2017 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28202793
20.
Retreatment with sofosbuvir and simeprevir of patients with hepatitis C virus genotype 1 or 4 who previously failed a daclatasvir-containing regimen.
Hepatology
; 63(6): 1809-16, 2016 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-26853230